Contact
searchSearch
HMP Global

Volume 14 - Issue 5 - May, 2002

Editorial
LETTER TO THE EDITOR:<br />
Letting the Air out of the Follow-up Balloon
08/01/2008
Humberto Dighero, MD; Pablo Sepúlveda, MD
To the Editor: We’ve read the editorial comment1 made by Dr. Turi on our study “Percutaneous Mitral Valvotomy: Six Year Follow-up”.2 Although we thank Dr. Turi for his insights, we disagree profoundly with the core of his criticism...
To the Editor: We’ve read the editorial comment1 made by Dr. Turi on our study “Percutaneous Mitral Valvotomy: Six Year Follow-up”.2 Although we thank Dr. Turi for his insights, we disagree profoundly with the core of his criticism...
To the Editor: We’ve read the...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Spontaneous Closure of a Perforation-Induced Coronary Artery Pseudoaneurysm<br />
CATHETER TECHNIQUES FOR THE TREATMENT OF ANEURYSMS
08/01/2008
Bassem Mikhail, MD; Robert J. Brewer, MD; Vivian L. Clark, MD
Coronary artery perforation is a rare but potentially fatal complication of percutaneous coronary interventions.1,2 Most cases are recognized at the time of the procedure. While some are identified as a localized collection of contrast...
Coronary artery perforation is a rare but potentially fatal complication of percutaneous coronary interventions.1,2 Most cases are recognized at the time of the procedure. While some are identified as a localized collection of contrast...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Rapid Evolution from Coronary Dissection to Pseudoaneurysm After Stent Implantation: A Glimpse at the Pathogenesis Using Intrava
08/01/2008
Jean Marc Weinstein, MRCP; Carlos Cafri, MD; Harel Gilutz, MD; Sergio Kobal, MD; Georgeta Esanu, MD; Reuben Illia, MD; Akram Abu-Ful, MD
Coronary dissection during percutaneous coronary intervention (PCI) occurs frequently and is associated with variable evolution, including the development of acute closure with serious clinical consequences. Stent sealing of the false lumen...
Coronary dissection during percutaneous coronary intervention (PCI) occurs frequently and is associated with variable evolution, including the development of acute closure with serious clinical consequences. Stent sealing of the false lumen...
Coronary dissection during...
08/01/2008
Journal of Invasive Cardiology
Case Report
Aortic Dissection Complicating Failed Coronary Stenting<br />
08/01/2008
Chiharu Kobayashi, MD; Mafumi Owa, MD; Mitsuru kagoshima, MD
Coronary dissection is a well-known complication of coronary interventions; however, proximal progression of the dissection into the aortic root happens rarely.1 The outcome and therapeutic strategy for this iatrogenic complication need to be...
Coronary dissection is a well-known complication of coronary interventions; however, proximal progression of the dissection into the aortic root happens rarely.1 The outcome and therapeutic strategy for this iatrogenic complication need to be...
Coronary dissection is a...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
Endovascular Treatment of Carotid Artery Aneurysms with Stent Grafts
08/01/2008
Debabrata Mukherjee, MD, MS; Marco Roffi, MD; Jay S. Yadav, MD
Aneurysms of the carotid arteries is a rare but well described entity. Cervical carotid artery aneurysms can cause cerebral embolism and transient ischemic attacks.1 Surgery, however, is often difficult because of the location and the damaged...
Aneurysms of the carotid arteries is a rare but well described entity. Cervical carotid artery aneurysms can cause cerebral embolism and transient ischemic attacks.1 Surgery, however, is often difficult because of the location and the damaged...
Aneurysms of the carotid...
08/01/2008
Journal of Invasive Cardiology
Commentary
Optimized Combination of Antiplatelet Treatment and Anticoagulation for Percutaneous Coronary <br />
Intervention: The Final Word is
08/01/2008
Rafael Beyar, MD, DSc, MPH; Luis Gruberg, MD
The term acute coronary syndromes (ACS) comprise a continuum of diseases of various risks and severities including unstable angina pectoris, non-Q and Q-wave myocardial infarction (MI) and sudden death.1 These conditions share a similar...
The term acute coronary syndromes (ACS) comprise a continuum of diseases of various risks and severities including unstable angina pectoris, non-Q and Q-wave myocardial infarction (MI) and sudden death.1 These conditions share a similar...
The term acute coronary...
08/01/2008
Journal of Invasive Cardiology
Early and Late Clinical and Angiographic<br />
Outcomes Following Terumo Coronary Stent Implantation
08/01/2008
T. Tian Lim, MD; Y. Teng Lim, MBBS; Y. Leng Lim, MBBS, PhD; Kean-Wah Lau, MBBS, MD; Tian Hai Koh, MBBS; Koon-Hou Mak, MBBS; Charles N. S. Chan, MBBS; Kean-Huat Neoh, MBBS; T. Damras, MD; H. Cheem Tan, MBBS
Coronary stenting has evolved into the principal non-balloon device in percutaneous coronary intervention (PCI) procedures.(1) Continual improvement in stent designs promises greater deliverability and durability. Indeed, widespread...
Coronary stenting has evolved into the principal non-balloon device in percutaneous coronary intervention (PCI) procedures.(1) Continual improvement in stent designs promises greater deliverability and durability. Indeed, widespread...
Coronary stenting has evolved...
08/01/2008
Journal of Invasive Cardiology
Angiopeptin-Eluting Stents: Observations in Human Vessels and Pig Coronary Arteries
08/01/2008
K. H. Chan, MRCP; Julian Gunn, MA, MD, MRCP; Terry Vick, PhD; Peter Stratford, PhD; David C. Cumberland, FACC; Cathy M. Holt, PhD; Nadim Malik, MBBS, MA, MD; Johanna Armstrong, PhD; Nadine Arnold
Coronary stenting is generally associated with lower rates of restenosis than balloon angioplasty.1,2 However, in-stent restenosis (ISR) remains a significant clinical problem.(3) Pharmacological inhibition of ISR has shown potential in...
Coronary stenting is generally associated with lower rates of restenosis than balloon angioplasty.1,2 However, in-stent restenosis (ISR) remains a significant clinical problem.(3) Pharmacological inhibition of ISR has shown potential in...
Coronary stenting is generally...
08/01/2008
Journal of Invasive Cardiology
Use of Clopidogrel Loading, Enoxaparin, and Double-Bolus Eptifibatide in the Setting of Early Percutaneous Coronary Intervention
08/01/2008
Amit Gupta, MD; Barry D. Bertolet, MD; Lonnie Miller, RCVT
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in...
08/01/2008
Journal of Invasive Cardiology
Unstable Angina In a Patient With a Single Sequential Saphenous Vein Bypass Graft <br />
Supplying the Entire Coronary Circulation
08/01/2008
Wiwun Tantibhedhyangkul, MD; J. Lawrence Stafford, MD
Case Description. A 72-year-old man was admitted to our institution with unstable angina pectoris. In 1980, he underwent single-vessel coronary artery bypass graft surgery (CABG) receiving a saphenous vein bypass graft (SVG) to the left...
Case Description. A 72-year-old man was admitted to our institution with unstable angina pectoris. In 1980, he underwent single-vessel coronary artery bypass graft surgery (CABG) receiving a saphenous vein bypass graft (SVG) to the left...
Case Description. A 72-year-old...
08/01/2008
Journal of Invasive Cardiology
Part II: Risk Stratification in Patients with Unstable Angina and Non-ST Segment Elevation Myocardial Infarction: Evidence-Based
08/01/2008
James E. Calvin, MD; Rami Doukky, MD
In last month’s issue of the Journal, we published Part I of this article. This month’s conclusion focuses on other risk stratification models and tools. Several major studies have established the benefit of glycoprotein (GP) IIb/IIIa...
In last month’s issue of the Journal, we published Part I of this article. This month’s conclusion focuses on other risk stratification models and tools. Several major studies have established the benefit of glycoprotein (GP) IIb/IIIa...
In last month’s issue of the...
08/01/2008
Journal of Invasive Cardiology
Clopidogrel Treatment Before Percutaneous <br />
Coronary Intervention Reduces Adverse Cardiac Events
08/01/2008
Ulf Berglund, MD; Arina Richter, MD, PhD
The benefit of platelet inhibition during percutaneous coronary intervention (PCI) has been known for some time.1 In recent years, the interest has focused on the platelet glycoprotein IIb/IIIa inhibitors, which block the final common pathway...
The benefit of platelet inhibition during percutaneous coronary intervention (PCI) has been known for some time.1 In recent years, the interest has focused on the platelet glycoprotein IIb/IIIa inhibitors, which block the final common pathway...
The benefit of platelet...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Treatment of a Giant Coronary Aneurysm with a Novel Technique: Scaffolding (Tunnel) Stenting to Support PTFE-Covered Stents: Ins
08/01/2008
Rosana Hernandez-Antolin, MD, PhD; Javier Escaned, MD, PhD; Manel Sabaté, MD, PhD; Fernando Alfonso, MD, PhD, FESC; Mauricio Lopez-Meneses, MD; Camino Bañuelos, MD; Alex Flores, MD; Antonio Fernandez-Ortiz, MD, PhD; Pablo Garcia, MD; Carlos Macaya, MD, PhD; Jaime Arias, MD
Coronary artery aneurysm (CAA) is an uncommon condition with a natural history and prognosis still obscure.1 Aneurysmal coronary artery disease is defined as coronary dilatation that exceeds the diameter of the adjacent reference vessel by...
Coronary artery aneurysm (CAA) is an uncommon condition with a natural history and prognosis still obscure.1 Aneurysmal coronary artery disease is defined as coronary dilatation that exceeds the diameter of the adjacent reference vessel by...
Coronary artery aneurysm (CAA)...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Subclavian Artery Pseudoaneurysm: Successful Exclusion with a Covered Self-Expanding Stent<br />
CATHETER TECHNIQUES FOR THE TREATME
08/01/2008
Nathan Laufer, MD; Ashish Pershad, MD; Jorge A. Hernandez, MD
Pseudoaneurysms are encapsulated hematomas that communicate with an artery because of an incomplete seal by the media. Although femoral artery pseudo-aneurysms occurring as a complication of cardiac catheterization are familiar to an...
Pseudoaneurysms are encapsulated hematomas that communicate with an artery because of an incomplete seal by the media. Although femoral artery pseudo-aneurysms occurring as a complication of cardiac catheterization are familiar to an...
Pseudoaneurysms are encapsulated...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
Obliteration of a Left Main Coronary Artery Aneurysm with a PTFE-Covered Stent<br />
CATHETER TECHNIQUES FOR THE TREATMENT OF ANEURY
08/01/2008
Maja Strozzi, MD; Alexander Ernst, MD, PhD; Ljiljana Banfic, MD
There are many reports in the literature about coronary artery aneurysms, their incidence, pathogenesis, clinical outcome and treatment.1–3 If asymptomatic, their progression, rupture or secondary embolization are unpredictable. Some...
There are many reports in the literature about coronary artery aneurysms, their incidence, pathogenesis, clinical outcome and treatment.1–3 If asymptomatic, their progression, rupture or secondary embolization are unpredictable. Some...
There are many reports in the...
08/01/2008
Journal of Invasive Cardiology
Standardized, Angiographically-Guided<br />
“Over-Dilatation” of Stents Using High-Pressure Technique Optimizes Results Without Incre
08/01/2008
Benny Johansson, MD; Mats Allared, MD; Bertil Borgencrantz, MD; Leif Brorson, MD; Hakan Geijer, MD; Thomas Kellerth, MD; Hans Olsson, MD; Asgrimur Ragnarsson, MD; Helge Skoglund, MD; Bertil Wennerblom, MD
The introduction of stents in clinical practice resulted in a reduction of the restenosis rate from 30–40% to 16–27% and a target lesion revascularization (TLR) rate of 6–15% after 6 months, although angio-guided stent implantation often...
The introduction of stents in clinical practice resulted in a reduction of the restenosis rate from 30–40% to 16–27% and a target lesion revascularization (TLR) rate of 6–15% after 6 months, although angio-guided stent implantation often...
The introduction of stents in...
08/01/2008
Journal of Invasive Cardiology
Commentary
A Simple Step Towards Better Stent Deployment
08/01/2008
Antonio Colombo, MD; Leo Finci, MD
The idea of achieving an optimal stent deployment is a simple one: a stent deployed in a lesion has to reach its nominal size which should be close to the measured vessel size, taking into account that the plaque is still there and that the...
The idea of achieving an optimal stent deployment is a simple one: a stent deployed in a lesion has to reach its nominal size which should be close to the measured vessel size, taking into account that the plaque is still there and that the...
The idea of achieving an optimal...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
May Letter to Readers
08/01/2008
Richard E. Shaw, PhD, FACC
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, a special teaching collection on catheter treatments for aneurysms, articles from four of the Journal special sections, and a case report. ...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, a special teaching collection on catheter treatments for aneurysms, articles from four of the Journal special sections, and a case report. ...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO&nbsp;–&nbsp;Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering&nbsp;Cleerly®&nbsp;LABS plaque analysis effective immediately. Aetna, which covers more than&nbsp;20+ million lives,...
DENVER, CO&nbsp;–&nbsp;Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering&nbsp;Cleerly®&nbsp;LABS plaque analysis effective immediately. Aetna, which covers more than&nbsp;20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its&nbsp;FDA 510(k)-cleared cvi42&nbsp;with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its&nbsp;FDA 510(k)-cleared cvi42&nbsp;with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris&nbsp;– HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received&nbsp;CE Mark approval&nbsp;for the HighLife Transcatheter Mitral Valve Replacement...
Paris&nbsp;– HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received&nbsp;CE Mark approval&nbsp;for the HighLife Transcatheter Mitral Valve Replacement...
Paris&nbsp;– HighLife SAS, a...
01/27/2026
Cath Lab Digest

May 2002 Volume 14 Issue 5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use